Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of Wasog
Overview
Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of WASOG is a reputable scientific publication dedicated to advancing knowledge and understanding of sarcoidosis, vasculitis, and other diffuse lung diseases. It features high-quality research articles, reviews, and case reports, providing a platform for experts to share their insights and discoveries in the field. This journal serves as a valuable resource for clinicians, researchers, and healthcare professionals seeking the latest developments in these complex respiratory conditions.
Details
Details
Abbr.
Sarcoidosis Vasc Diffuse Lung Dis
Start
1996
End
Continuing
Frequency
Quarterly, 2014-
p-ISSN
1124-0490
e-ISSN
2532-179X
Country
Italy
Language
English
Metrics
Metrics
h-index / Ranks: 5603
65
SJR / Ranks: 11087
354
CiteScore / Ranks: 7822
3.40
JIF / Ranks: 5932
1.6
Recent Articles
1.
Ljilja Posavec A, Cvetkovic Kucic D, Zagorec N, Malnar L, Lalic K, Zelenika M, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024052.
PMID: 39655598
Background: Some of the hospitalized patients after severe COVID-19 pneumonia experience significant fall in peripheral saturation despite optimal treatment. Because of immune dysregulation in COVID-19 there are indications that prolonged...
2.
Cao H, Chen X, Song Y, Xue T, Xue Z, Zhang G, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024065.
PMID: 39655597
This study aimed to investigate the potential clinical factors that may be associated with the incidence of lung cancer. A total of 150 individuals were enrolled in this cohort study,...
3.
Pacheco J, Santos A, Catarata M, Freitas S
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024051.
PMID: 39655596
Background: Interstitial lung diseases have high mortality associated with hospitalization for decompensation. There are doubts about the factors involved in the progression of fibrosis, for example the role played by...
4.
Tetikkurt C, Kubat B, Sayman H, Yanardag H, Bilir M
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024064.
PMID: 39655595
Background: Sarcoidosis is a granulomatous disease of unknown origin. Conventional laboratory and imaging modalities may lead to equivocal conclusions for sarcoidosis diagnosis. 68Ga-citrate PET/CT has been utilized in the diagnosis...
5.
Khabbazi A, Rahimi M, Malek Mahdavi A, Farzaneh R, Daneshvar S, Naseri A, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024053.
PMID: 39655594
Vasculitis is a group of uncommon diseases characterized by inflammation of blood vessels, which contributes to the organ ischemia and damage. Cigarette smoke contains a high concentration of various toxins,...
6.
Kerget B, Gulbahar B, Cinar I, Alper F, Saglam L
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024054.
PMID: 39655593
Background: Post-covid pulmonary fibrosis (PCPF) is an essential cause of hypoxic respiratory failure, especially in patients with severe COVID-19 infection. In our study, we aimed to compare the effectiveness of...
7.
Seleoglu I, Demirel A
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024061.
PMID: 39655592
Background And Aim: Interstitial lung disease (ILD) is the major contributor to mortality in between chronic lung diseases. ILD originates from voluminous pathophysiological factors. One of the reasons is connective...
8.
Kotsiou O, Kirgou P, Tzouvelekis A, Kolilekas L, Manali E, Papiris S, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024055.
PMID: 39655591
Background And Aim: There is limited data on the prevalence of SARS-COV-2 in sarcoidosis patients and the underlying parameters linked to severity. We aimed to conduct a national multicenter study...
9.
Kara S, Mogulkoc N, Kirkil G, Cetinkaya E, Ozbudak O, Kilic T, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024050.
PMID: 39655590
Background And Aim: Lung cancer is one of the significant comorbidities seen in patients with Idiopathic Pulmonary Fibrosis (IPF). However, there is limited data on non-IPF Pulmonary Fibrosis (PF) patients...
10.
Gargouri R, Fenina W, Al Juaidi M, Feki W, Fendri H, Msaed S, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Dec;
41(4):e2024060.
PMID: 39655589
Background And Aim: Sarcoidosis is a systemic disease of unknown cause characterized by the formation of non-caseating granulomatous inflammation in various organs, mainly lungs and intrathoracic lymph nodes. Its clinical...